Brainstorm Health: Novartis $2.1 Million Drug, Brexit Fallout, Jakafi Drug Approval

Happy Friday, readers! On Friday, drug giant Novartis got the Food and Drug Administration (FDA) green light for a first-of-its-kind gene therapy to treat a rare, devastating genetic muscle-wasting disorder called spinal muscular atrophy (SMA). This victory was largely expected; all eyes, however, were on where Novartis would place the treatment’s list price. Speculation was […]

Out of the Office: Easing the Stress of Packing With Away CEO Steph Korey

Going on vacation should be fun and relaxing. Except when you’re packing. What do I bring? Do I really need all these clothes? Will it all fit? Away is a travel company that makes suitcases, bags, and other travel products. So what better way to ease the stress of packing than to learn from the […]

While SpaceX’s Internet Satellites Launch, a Rival’s Stock Price Blasts Off

Elon Musk’s SpaceX got a stratospheric number of headlines this week for lofting into orbit the first 60 operational satellites for its planned Starlink Internet service. But the startup will need to launch hundreds more satellites before offering even rudimentary Internet service from space–and almost 12,000 satellites to offer global, high-speed coverage. Meanwhile, almost no […]

Could Ford Buy Tesla? Here’s How Likely A “Doomsday” Scenario Is

Former Tesla bulls have been bailing on the company. The stock continues to drop. Bond prices are at low levels. The auto maker is burning through $1 billion in cash a quarter, the cash from the latest $2.7 billion funding round will be gone within ten months, and demand is falling off. One of the […]